DK1308444T3 - Substitueret 2(2,6 dioxo-3-fluorpiperidin-3-yl)-isoindoliner og deres anvendelse til reduktion af TNFalfa-niveau'er - Google Patents

Substitueret 2(2,6 dioxo-3-fluorpiperidin-3-yl)-isoindoliner og deres anvendelse til reduktion af TNFalfa-niveau'er

Info

Publication number
DK1308444T3
DK1308444T3 DK02028237T DK02028237T DK1308444T3 DK 1308444 T3 DK1308444 T3 DK 1308444T3 DK 02028237 T DK02028237 T DK 02028237T DK 02028237 T DK02028237 T DK 02028237T DK 1308444 T3 DK1308444 T3 DK 1308444T3
Authority
DK
Denmark
Prior art keywords
dioxo
fluoropiperidin
isoindolines
levels
tnfalfa
Prior art date
Application number
DK02028237T
Other languages
Danish (da)
English (en)
Inventor
Hon-Wah Man
George W Muller
David I Stirling
Roger Shen-Chu Chen
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/976,140 external-priority patent/US5874448A/en
Priority claimed from US09/042,274 external-priority patent/US5955476A/en
Application filed by Celgene Corp filed Critical Celgene Corp
Application granted granted Critical
Publication of DK1308444T3 publication Critical patent/DK1308444T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK02028237T 1997-11-18 1998-11-17 Substitueret 2(2,6 dioxo-3-fluorpiperidin-3-yl)-isoindoliner og deres anvendelse til reduktion af TNFalfa-niveau'er DK1308444T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/976,140 US5874448A (en) 1997-11-18 1997-11-18 Substituted 2-(2,6 dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing TNFα levels
US09/042,274 US5955476A (en) 1997-11-18 1998-03-13 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and method of reducing inflammatory cytokine levels
EP98958016A EP1062214B1 (en) 1997-11-18 1998-11-17 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels

Publications (1)

Publication Number Publication Date
DK1308444T3 true DK1308444T3 (da) 2006-09-18

Family

ID=26719049

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02028237T DK1308444T3 (da) 1997-11-18 1998-11-17 Substitueret 2(2,6 dioxo-3-fluorpiperidin-3-yl)-isoindoliner og deres anvendelse til reduktion af TNFalfa-niveau'er

Country Status (14)

Country Link
EP (3) EP1062214B1 (no)
AT (2) ATE233753T1 (no)
AU (1) AU752958B2 (no)
CY (1) CY1106100T1 (no)
CZ (1) CZ299808B6 (no)
DE (2) DE69834668T2 (no)
DK (1) DK1308444T3 (no)
ES (2) ES2192342T3 (no)
FI (1) FI20001192A (no)
HK (1) HK1054381B (no)
NO (1) NO318737B1 (no)
PT (1) PT1308444E (no)
SI (1) SI1308444T1 (no)
SK (1) SK7382000A3 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299253B6 (cs) * 1998-03-16 2008-05-28 Celgene Corporation Isoindolinový derivát, jeho použití pro výrobu léciva a farmaceutická kompozice tento derivát obsahující
US20050100529A1 (en) * 2003-11-06 2005-05-12 Zeldis Jerome B. Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE4422237A1 (de) * 1994-06-24 1996-01-04 Gruenenthal Gmbh Verwendung von Lactamverbindungen als pharmazeutische Wirkstoffe
DE19613976C1 (de) * 1996-04-09 1997-11-20 Gruenenthal Gmbh Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
HU228769B1 (en) * 1996-07-24 2013-05-28 Celgene Corp Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and their use for production of pharmaceutical compositions for mammals to reduce the level of tnf-alpha
ES2339425T3 (es) * 1996-07-24 2010-05-20 Celgene Corporation 2-(2,6-dioxopiperidin-3-il)-ftalimidas y -1-oxoisoindolinas sustituidas y procedimiento para reducir los niveles de tnf-alfa.
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines

Also Published As

Publication number Publication date
EP1062214A1 (en) 2000-12-27
EP1308444A1 (en) 2003-05-07
DE69811962T2 (de) 2003-08-28
CY1106100T1 (el) 2011-06-08
CZ299808B6 (cs) 2008-12-03
CZ20001822A3 (cs) 2000-11-15
AU1413899A (en) 1999-09-27
ATE327228T1 (de) 2006-06-15
PT1308444E (pt) 2006-08-31
SK7382000A3 (en) 2000-12-11
NO318737B1 (no) 2005-05-02
HK1054381A1 (en) 2003-11-28
AU752958B2 (en) 2002-10-03
ES2262753T3 (es) 2006-12-01
EP1710242A1 (en) 2006-10-11
ES2192342T3 (es) 2003-10-01
SI1308444T1 (sl) 2007-04-30
FI20001192A (fi) 2000-07-14
EP1308444B1 (en) 2006-05-24
DE69811962D1 (de) 2003-04-10
DE69834668D1 (de) 2006-06-29
DE69834668T2 (de) 2007-01-11
HK1054381B (zh) 2006-10-13
ATE233753T1 (de) 2003-03-15
NO20002529D0 (no) 2000-05-16
EP1062214B1 (en) 2003-03-05
NO20002529L (no) 2000-06-30

Similar Documents

Publication Publication Date Title
TR200002627T2 (tr) İkameli 2-(2,6- (Diokso-3-floropiperidin-3-İI) -izoindolinler ve TNF alfa seviyelerini düşürmek için kullanılmaları
TR201005282T2 (tr) Sübstitüe edilmiş 2-(2,b-dioksopiperidin-3-il)-ftalimidler ve -1-oksoizoindolinler ve TNF alfa seviyelerini düşürmek için yöntem.
HK1153736A1 (en) Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing tnf alpha levels 2-(26--3-)--1-
NO941161D0 (no) Flyveaske-sementeringssammensetninger og metoder
NO941929D0 (no) Tokotrienoler og tokotrienol-lignende sammensetninger og fremgangsmåter for deres anvendelse
NO973046D0 (no) Elastiske sementsammensetninger og fremgangsmåte
DK2305248T3 (da) Substituerede phenethylsulfoner og fremgangsmåde til reduktion af tnf-alfa-niveauer
NO973048L (no) Elastiske brönnsementsammensetninger og fremgangsmåter
DE69034163D1 (de) Spontane Sprach- und Datenbenachrichtigung
NO910816D0 (no) Forbedrede betongblandinger og deres anvendelse.
DE69415304D1 (de) Digitales sprachwiedergabe- und digitales spracheditiergerät
NO933652D0 (no) Ioderte benzoylacetater og -ketater
DK1308444T3 (da) Substitueret 2(2,6 dioxo-3-fluorpiperidin-3-yl)-isoindoliner og deres anvendelse til reduktion af TNFalfa-niveau'er
NO973047L (no) Elastiske brönnsementsammensetninger og fremgangsmåter
DE69427894T2 (de) Pegeleinstellungs- und Enscheidungsschaltung
KR930005862U (ko) 음성 모드 선택 및 더빙회로
KR950002224U (ko) 확산로의 로젯현상방지 장치
KR950021891U (ko) 파워 엠프를 이용한 전화 인터페이스 회로
KR930011934U (ko) 채널 업/다운 키와 트래킹 업/다운 키의 공용화 회로
KR940023747U (ko) 음성출력 제한회로
IT217447Z2 (it) Mobile articolato per ufficio o studio con piano ausiliario e cassettiera estraibili simultaneamente
KR950012717U (ko) 음성출력 증폭회로
NO870574L (no) Myk lyd- og termisk isolerende flerlagsstruktur for selvbaerende konstruksjoner samt anvendelse derav.
ITMI940157A0 (it) Piano estensibile ed elevabile sinoronicamente